Our Company
Biopharmaceutical Acceleration Model®
Dynamic Assembly®
Kinetic™
Syneos One®
The Trusted Process®
Our Leadership
Our Vision, Mission and Values
Resource Library
Events
Awards
Site Relationships
Our Office Locations
Solutions
Clinical Development
Full Service
Decentralized Solutions
Bioanalytical Solutions
Early Phase
Phase II - III
Phase IIIb - IV
Real World and Late Phase
Medical Device and Diagnostics
FSP 360
Biostatistics and Statistical Programming
Clinical Data Management
Clinical Development Services Project Management
Clinical Monitoring
Drug Safety and Pharmacovigilance
Investigator Management Solutions
Medical Writing and Communications
Rater Training
Site Start Up
Site and Patient Access
Trial Master File Operations
Commercialization
Advertising
AnswerSuite
Behavioral Insights
Brand Commercialization
Brand Naming and Development
Clinical Field Teams
Commercial Model of the Future
Commercial Recruiting Solutions
Communications
Deployment Solutions
Digital and Social Media
Health Economics and Outcomes Research
Integrated Commercial Solutions
Medical Affairs Transformation
Medical Communications
Policy and Advocacy
Portfolio Strategy
Public Relations
REMS and Risk Management (PMO)
Reputation and Risk Management
Selling Solutions
Training and Learning Solutions
Value and Access
Consulting
Commercial Advisory Group
Portfolio Strategy and Transactions
Health Economics and Outcomes Research
Product and Franchise Strategy
Value and Access
Customer and Digital Engagement
Scientific and Medical Affairs Advisory Group
Medical Affairs
Quality and Compliance
Regulatory
Risk and Program Management Advisory Group
REMS and Risk Management (PMO)
R&D Advisory Group
Research and Development
Syneos One®
Therapeutic Expertise
Therapeutic Areas
Cardiovascular
Central Nervous System
CNS Analgesia
CNS Clinical Surveillance Team
CNS Neurology
CNS Psychiatry
Endocrine and Metabolic
Gastroenterology
Immunology and Inflammation
Infectious Disease and Vaccines
Ophthalmology
Respiratory
Women's Health
Oncology and Hematology
Targeted Therapies
Novel and Emerging Therapies
Immuno-Oncology
Cross-Functional Solutions
Biosimilars
Cell and Gene Therapy
Patient Voice
Pediatrics
Rare Diseases
Our Experience Hub
Insights Hub
Careers
インサイト ハブ
中途採用
新卒採用 (日本)
News
In The News
Press Releases
Press Kit
Investors
Investigators
Transparency
Suppliers
Supplier Code of Conduct
Supplier Diversity and Inclusion
Supplier Terms and Conditions
Contact
English
Français Canadien
日本語
Search form
Search
Home
Our Company
Resource Library
Resource Library
All Media Types
Fact Sheet
Flyer
Poster
All Solutions
Bioanalytical Solutions
Biosimilars
Biotechnology
Cardiovascular
Catalyst
Cell and Gene Therapy
Clinical Development
Clinical and Commercial
Early Phase
Endocrinology
Health Economics and Outcomes Research
Immunology and Inflammation
Medical Writing
Oncology and Hematology
Ophthalmology
Rare Disease
Real World Evidence
Safety and Pharmacovigilance
Strategic Resourcing
Translational Science
Value and Access
Women's Health
All Topics
505(b)(2)
Abuse Liability
Asia Pacific
Bioanalytical Solutions
Biomarker Imaging
Biosimilars
Catalyst
Cell and Gene Therapy
Clinical
Clinical Development
Clinical Trials
Clinical and Commercial
Commercialization
Critical Reagents
Early Phase
Functional Service Provider
Immunology and Inflammation
Immunotherapies
Medical Affairs
NASH
Non-Malignant Hematology
Oncology
Oncology and Hematology
Ophthalmology
Pharmacometrics
Rare Disease
Real World Evidence
Safety and Pharmacovigilance
Site Payments
Translational Science
Value and Access
Women's Health
Sort by
Date
Order
Least Recent
Most Recent
Site Payments
Improving Site Relationships by Leveraging Investigator Payment Solutions
05.19.21
NASH
Leading the Way in NASH and Hepatology Clinical Trials
02.15.21
Rare Disease
Syneos Health Rare Disease Consortium Fact Sheet
10.30.20
Oncology and Hematology
Oncology Expertise at All Levels
09.21.20
Clinical and Commercial
We Know Biotechnology Is Different
09.21.20
Oncology and Hematology
Immunotherapies
Immunotherapy in Solid Tumors
09.21.20
Cell and Gene Therapy
Clinical Development
Syneos Health Cell and Gene Therapy Consortium
09.18.20
Clinical
Hematology-Oncology Fact Sheet
05.28.20
Non-Malignant Hematology
Nonmalignant Hematology Fact Sheet
05.28.20
Clinical and Commercial
Leading Through Uncertainty Amidst the Global Pandemic
03.18.20
Oncology and Hematology
Oncology
Non-Malignant Hematology
Targeted Therapies for Solid Tumors
02.21.20
Oncology and Hematology
End-to-End Expertise and Regulatory Knowledge in Early Phase Oncology
02.21.20
Load More
